Search for Clinical Trial Results

Sponsored By

Myeloid Sarcoma - 6 Studies Found

Status Study
Recruiting Study Name: CIP-613, Cytarabine, and Mitoxantrone Hydrochloride in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Granulocytic Sarcoma
Condition:
  • Granulocytic Sarcoma
  • Recurrent Adult Acute Myeloid Leukemia Date: 2015-06-25
    Interventions:
    • Drug: 6,8-Bis(benzylthio)octanoic Acid

Recruiting Study Name: Bortezomib and Sorafenib Tosylate in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia
Condition:
  • Leukemia Cutis
  • Myeloid Sarcoma
  • Drug: Asparaginase Given IM
Recruiting Study Name: Provision of TCRγδ T Cells and Memory T Cells Plus Selected Use of Blinatumomab in Naïve T-cell Depleted Haploidentical Donor Hematopoietic Cell Transplantation for Hematologic Malignancies Relapsed or Refractory Despite Prior Transplantation
Condition:
  • Acute Lymphoblastic Leukemia (ALL)
  • Acute Myeloid Leukemia (AML)
  • Drug: Anti-thymocyte globulin (rabbit)

Terminated Study Name: Repeat Transplantation for Relapsed or Refractory Hematologic Malignancies Following Prior Transplantation
Condition:
  • Acute Lymphoblastic Leukemia (ALL)
  • Acute Myeloid Leukemia (AML)
  • Drug: Cyclophosphamide Given i
Recruiting Study Name: Vosaroxin and Infusional Cytarabine in Treating Patients With Untreated Acute Myeloid Leukemia
Condition:
  • Acute Myeloid Leukemia
  • Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
    Date: 2016-01-14
    Interventions:
    • Drug: Cytarabine Given IV
Completed Study Name: PET-CT in AML for Detection of Extramedullary AML Manifestations
Condition: Newly Diagnosed or Relapsed Acute Myeloid Leukemia
Date: 2011-01-14